CLDX compared with IDXX: revenue, margins and what each company keeps, and the suppliers and customers both name

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

IDXXIdexx Laboratories Inc

Mkt capRevenueRevenue

Compare

CLDXCelldex Therapeutics, Inc.

IDXXIdexx Laboratories Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CLDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.8%▲+0.36%×0.04

May 8 '26±7.6%▲+1.95%×0.25

Q1 FY26±13.6%▼−0.58%×0.04

Q3 FY25±17.3%▲+7.50%×0.43

IDXX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.6%▲+21.85%×2.55

Q2 FY26±8.4%▲+3.57%×0.43

= impliedCLDX realized, solidIDXX realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±8.0%

▼−0.03%

×0.00

Feb 2 '26±8.9%▼−4.60%×0.52

CLDXCelldex Therapeutics, Inc.

29.68▲+2.19%· post 29.70

Mkt cap$2.3BRevenue$22,000Q2 FY26Revenue$7MFY24

IDXXIdexx Laboratories Inc

672.00▲+0.05%· post 669.10

ClosedNov 3 '26

Mkt cap$52.9BRevenue$1.2BQ3 FY26Revenue$4.3BFY25

Compare

ClosedNov 3 '26

CLDXCelldex Therapeutics, Inc.

IDXXIdexx Laboratories Inc

29.68▲+2.19%post 29.70

Price

672.00▲+0.05%post 669.10

$2.3B

Mkt cap

$52.9B

Q2 FY26$22,000

Revenue

$1.2BQ3 FY26

FY24$7M

Revenue

$4.3BFY25

CLDX29.68▲+2.19%vsIDXX672.00▲+0.05%ClosedNov 3 '26